Filing Flows › Comparisons › VTVT vs ROIV
vTv Therapeutics vs Roivant Sciences: VTVT and ROIV compared
vTv Therapeutics is the larger company: $36.8M of revenue in its latest quarter (Q1 2026) against $35.1M for Roivant Sciences (Q2 FY27). vTv Therapeutics is more profitable, with an operating margin of 63.1% against -763.2%.
Where the money goes: VTVT and ROIV
vTv Therapeutics (VTVT) · Q1 2026
vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.
Roivant Sciences (ROIV) · Q2 FY27
Roivant Sciences, Q2 FY27: revenue $35.1M (22× year over year), operating margin -763.2%, net loss $137M, operating cash flow $594M. The chart follows the revenue to costs, profit and cash.
| vTv Therapeutics (VTVT) | Roivant Sciences (ROIV) | |
|---|---|---|
| Latest quarter | Q1 2026 | Q2 FY27 |
| Revenue | $36.8M | $35.1M |
| Revenue growth, Y/Y | — | 22× |
| Operating margin | 63.1% | -763.2% |
| Net earnings | $24.1M | −$137M |
| Net margin | 65.5% | -390.7% |
| Operating cash flow | $9.2M | $594M |
| Free cash flow | — | $594M |
Where the revenue comes from
Roivant Sciences
- Product revenue, net: $31.0M (88%)
- License, milestone and other revenue: $4.2M (12%)
Questions
Which is bigger, vTv Therapeutics or Roivant Sciences?
vTv Therapeutics is the larger company: $36.8M of revenue in its latest quarter (Q1 2026) against $35.1M for Roivant Sciences (Q2 FY27).
Is vTv Therapeutics or Roivant Sciences growing faster?
vTv Therapeutics is more profitable, with an operating margin of 63.1% against -763.2%.
More: vTv Therapeutics earnings · how vTv Therapeutics makes money · Roivant Sciences earnings · how Roivant Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 13, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.